Abstract:Abstract Hypertension in midlife contributes to cognitive decline and is a modifiable risk factor for dementia. The relationship between late-life hypertension and dementia is less clear. We have investigated the relationship of blood pressure and hypertensive status during late life (after 65 years) to post-mortem markers of Alzheimer’s disease (amyloid-β and tau loads); arteriolosclerosis and cerebral amyloid angiopathy; and to biochemical measures of ante-mortem cerebral oxygenation (the myelin-associated glycoprotein:proteolipid protein-1 ratio, which is reduced in chronically hypoperfused brain tissue, and the level of vascular endothelial growth factor-A, which is upregulated by tissue hypoxia); blood–brain barrier damage (indicated by an increase in parenchymal fibrinogen); and pericyte content (platelet-derived growth factor receptor β, which declines with pericyte loss), in Alzheimer’s disease (n = 75), vascular (n = 20) and mixed dementia (n = 31) cohorts. Systolic and diastolic blood pressure measurements were obtained retrospectively from clinical records. Non-amyloid small vessel disease and cerebral amyloid angiopathy were scored semiquantitatively. Amyloid-β and tau loads were assessed by field fraction measurement in immunolabelled sections of frontal and parietal lobes. Homogenates of frozen tissue from the contralateral frontal and parietal lobes (cortex and white matter) were used to measure markers of vascular function by enzyme-linked immunosorbent assay. Diastolic (but not systolic) blood pressure was associated with the preservation of cerebral oxygenation, correlating positively with the ratio of myelin-associated glycoprotein to proteolipid protein-1 and negatively with vascular endothelial growth factor-A in both the frontal and parietal cortices. Diastolic blood pressure correlated negatively with parenchymal amyloid-β in the parietal cortex. In dementia cases, elevated late-life diastolic blood pressure was associated with more severe arteriolosclerosis and cerebral amyloid angiopathy, and diastolic blood pressure correlated positively with parenchymal fibrinogen, indicating blood–brain barrier breakdown in both regions of the cortex. Systolic blood pressure was related to lower platelet-derived growth factor receptor β in controls in the frontal cortex and in dementia cases in the superficial white matter. We found no association between blood pressure and tau. Our findings demonstrate a complex relationship between late-life blood pressure, disease pathology and vascular function in dementia. We suggest that hypertension helps to reduce cerebral ischaemia (and may slow amyloid-β accumulation) in the face of increasing cerebral vascular resistance, but exacerbates vascular pathology.

Hypertension, Neurovascular Dysfunction, and Cognitive Impairment

Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts

Hypertension-induced cognitive impairment: from pathophysiology to public health

Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden

Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers

Blood Pressure and Cognitive Function in Older Adults

Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association

Association of Hypertension with Different Cognitive Disorders

Beyond Hypertension: Examining Variable Blood Pressure's Role in Cognition and Brain Structure

The Role of Hypertension in Cognitive Dysfunction

Blood Pressure Control and Protection of the Aging Brain

A Translational Perspective on the Interplay Between Hypertension, Inflammation and Cognitive Impairment

Hypertension and Mild Cognitive Impairment: State-of-the-Art Review

The Impact of Hypertension on Cognitive Decline and Alzheimer's Disease and Its Management: A Systematic Review

The effects of hypertension on the cerebral circulation

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Effects of Hypertension on Alzheimer's Disease: Updates in Pathophysiological and Neuroimaging Findings

Shedding Light on the Effects of Blood Pressure on Cognitive Decline and Dementia Risk by Way of Neurobiological Evidence

Cerebral Autoregulation in Hypertension and Ischemic Stroke: A Mini Review

Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention

Elevated late-life blood pressure may maintain brain oxygenation and slow amyloid-β accumulation at the expense of cerebral vascular damage